...
首页> 外文期刊>Advances in Experimental Medicine and Biology >Rationally-designed Multivalent Architectures for Mimicking Homotrimers of CD40L, a Member of the TNF Superfamily
【24h】

Rationally-designed Multivalent Architectures for Mimicking Homotrimers of CD40L, a Member of the TNF Superfamily

机译:合理设计的模拟CD40L(TNF超家族成员)的同三聚体的多价体系结构

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ligands and receptors of the TNF superfamilies play a central role in the organization and function of the immune system [1]. Ligands of the TNF-family, share a common structural motif. Monomers self-assemble around a three-fold symmetry axis to form non-covalent homotrimers that can each bind three receptor molecules. Interaction between CD40, a member of the TNF receptor superfamily, and its ligand CD40L, a 39 kDa glycoprotein is essential for the development of humoral and cellular immune responses. Selective blockade or activation of this pathway provides the ground for the development of new treatments against immunologically based-diseases and malignancies.Synthetic multivalent ligands, owing to the presence of multiple copies of a recognition motif attached to a central scaffold, can mediate clustering of cell surface receptors and thereby function as effector molecules [2]. We have shown previously that rigid trimeric scaffolds can serve to distribute a CD40-binding motif with geometry and distances that could match that of the natural CD40L protein (Figure 1) [3,4]. A short sequence from the surface of CD40L, encompassing three "hot-spot" residues (Lysl43, Tyrl45 and Tyrl46) critical for binding to CD40, was chosen as a CD40 binding motif.
机译:TNF超家族的配体和受体在免疫系统的组织和功能中起着核心作用[1]。 TNF家族的配体具有共同的结构基序。单体围绕三重对称轴自组装,形成可以各自结合三个受体分子的非共价同源三聚体。 TNF受体超家族成员CD40与它的配体CD40L(一种39 kDa糖蛋白)之间的相互作用对于体液和细胞免疫应答的发展至关重要。该途径的选择性阻断或激活为开发针对基于免疫学的疾病和恶性肿瘤的新疗法奠定了基础。合成的多价配体由于存在连接在中央支架上的识别基序的多个拷贝而可以介导细胞团聚表面受体,因此起效应分子的作用[2]。先前我们已经表明,刚性三聚体支架可以起到分布CD40结合基序的作用,其几何结构和距离可以与天然CD40L蛋白的几何结构和距离相匹配(图1)[3,4]。选择来自CD40L表面的短序列,其包含对结合CD40至关重要的三个“热点”残基(Lysl43,Tyr145和Tyrl46),作为CD40结合基序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号